The access to colorectal cancer screening in Thai average-risk population: a situational study
- PMID: 40890762
- PMCID: PMC12400776
- DOI: 10.1186/s12913-025-13435-9
The access to colorectal cancer screening in Thai average-risk population: a situational study
Abstract
Background: Screening of colorectal cancer (CRC) is a national policy of Thailand to support early cancer detection. However, most of the Thai average-risk population does not have access to screening. This study aimed to investigate the prevalence of access to CRC screening of the average-risk population in Thailand and examine the factors influencing access to CRC screening based on Andersen’s behavioral model.
Methods: This cross-sectional study was conducted in seven primary healthcare centers in all regions of Thailand. A sample of 530 Thai average-risk population aged 50 to 70 years was recruited and completed a survey to identify predisposing, enabling, and need factors, and access to CRC screening was determined. Logistic regression was applied to analyze factors influencing access to CRC screening.
Results: The prevalence of access to CRC screening in this study was 51.5%. The reception of information were the most significant enabling factors for access to CRC screening. The odds ratio of access to CRC screening increased by 4.23 times when the reception of information score increased by one unit (p < 0.001) when adjusted for other variables. In addition, awareness was a significant predisposing factor, and comorbidity was a significant need factor.
Conclusions: The prevalence of access to CRC screening in Thailand remains lower than the global average screening rate for CRC. This study informs reception of information is crucial to promote access to CRC screening by advising CRC screening among the average-risk population, particularly people who have less comorbidity. Relevant information materials should be developed and disseminated to the public to raise awareness among the population.
Keywords: Access to care; Average-risk population; Colorectal cancer screening; Primary healthcare centers; Situational analysis.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical certificate approval was received from Institutional Review Board, Faculty of Nursing, Mahidol University, project number IRB-NS2023/799.2808. In addition, this study received certificate approval and permissions from the director of each hospital. The informed consent was obtained from all participants. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Adherence to colorectal cancer screening with multi-target stool DNA testing among first-time average-risk users in federally qualified health centers.Curr Med Res Opin. 2025 Jun;41(6):983-993. doi: 10.1080/03007995.2025.2529984. Epub 2025 Jul 10. Curr Med Res Opin. 2025. PMID: 40620139
-
Disparities in Uptake of the 2021 US Preventive Services Task Force Colorectal Cancer Screening Recommendations Among Adults Aged 45 to 49 Years.Dis Colon Rectum. 2025 Aug 1;68(8):1010-1016. doi: 10.1097/DCR.0000000000003789. Epub 2025 Apr 29. Dis Colon Rectum. 2025. PMID: 40300645
-
Cascade colorectal cancer screening guidelines: a global conceptual model.J Clin Gastroenterol. 2011 Apr;45(4):297-300. doi: 10.1097/MCG.0b013e3182098e07. J Clin Gastroenterol. 2011. PMID: 21301355
-
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer.JAMA. 2025 Jul 1;334(1):56-63. doi: 10.1001/jama.2025.7515. JAMA. 2025. PMID: 40455622
-
NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.NIH Consens State Sci Statements. 2010 Feb 4;27(1):1-31. NIH Consens State Sci Statements. 2010. PMID: 20140035
References
-
- World Health Organization. Data visualization tools for exploring the global cancer burden in 2022. https://gco.iarc.fr/today/home (2022). Accessed 4 Apr 2024.
-
- National Cancer Institute of Thailand. Hospital-based cancer registry 2021. https://www.nci.go.th/e_book/hosbased_2564/index.html (2022). Accessed 4 Apr 2024.
-
- Bray F, Laversanne M, Sung H, Ferlay J, Soerjomataram I. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. - PubMed
LinkOut - more resources
Full Text Sources